Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000066

Director sold 1,666 shares at $18.37 ($30,604)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-15 Sale : show line 1 in the form 10b5-1 −1,666 $18.37 $30,604 121,375 D
Open-market sales · 1,666 sh · avg $18.37 · $30,604
Loading xslF345X05/wk-form4_1708468690.xml…